Iconovo logo

Iconovo Investor Relations Material

Iconovo AB develops and licenses inhalation devices for inhaled medicine. The company’s product portfolio includes the Icon, a disposable handheld inhaler, which is a solution for respiratory diseases; Clickhaler, a drug delivery inhaler that is used to treat respiratory airways inflammation and asthma; and Easyhaler, a powder inhaler that is used for the treatment of asthma and chronic obstructive pulmonary disease.

Upcoming events for

Q3 20222022-10-28

Latest company events

More about Iconovo

Ticker symbol

ICO

Country

Sweden

Investor Relations Page

https://iconovo.se/investors/

Dig deeper into the Iconovo fundamentals on Quartr.

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
App store link
Android play link
Quartr app screenshot